Annual Short Term Debt
$679.90 K
+$10.30 K+1.54%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual short term debt is $679.90 thousand, with the most recent change of +$10.30 thousand (+1.54%) on December 31, 2023.
- During the last 3 years, ENTO annual short term debt has risen by +$70.10 thousand (+11.50%).
- ENTO annual short term debt is now -89.66% below its all-time high of $6.58 million, reached on December 1, 2015.
Performance
ENTO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$79.50 K
-$175.50 K-68.82%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly short term debt is $79.50 thousand, with the most recent change of -$175.50 thousand (-68.82%) on September 1, 2024.
- Over the past year, ENTO quarterly short term debt has dropped by -$600.40 thousand (-88.31%).
- ENTO quarterly short term debt is now -99.20% below its all-time high of $9.93 million, reached on September 1, 2016.
Performance
ENTO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ENTO Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | -88.3% |
| 3 y3 years | +11.5% | -82.3% |
| 5 y5 years | +166.6% | -96.2% |
ENTO Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.5% | +1.5% | -89.0% | +23.4% |
| 5 y | 5-year | -57.6% | +11.5% | -98.5% | +23.4% |
| alltime | all time | -89.7% | +338.1% | -99.2% | -100.0% |
Entero Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $79.50 K(-68.8%) |
| Jun 2024 | - | $255.00 K(-44.3%) |
| Mar 2024 | - | $458.00 K(-32.6%) |
| Dec 2023 | $679.90 K(+1.5%) | $679.90 K(+941.2%) |
| Sep 2023 | - | $65.30 K(-69.9%) |
| Jun 2023 | - | $217.00 K(-51.6%) |
| Mar 2023 | - | $448.30 K(-33.0%) |
| Dec 2022 | $669.60 K(-6.9%) | - |
| Dec 2022 | - | $669.60 K(+939.8%) |
| Sep 2022 | - | $64.40 K(-71.3%) |
| Jun 2022 | - | $224.60 K(-52.6%) |
| Mar 2022 | - | $473.60 K(-34.1%) |
| Dec 2021 | $719.20 K(+17.9%) | $719.20 K(+658.6%) |
| Sep 2021 | - | $94.80 K(-63.3%) |
| Jun 2021 | - | $258.10 K(-36.1%) |
| Mar 2021 | - | $403.80 K(-33.8%) |
| Dec 2020 | $609.80 K | $609.80 K(+721.8%) |
| Sep 2020 | - | $74.20 K(-98.6%) |
| Jun 2020 | - | $5.49 M(+65.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.32 M(+106.9%) |
| Dec 2019 | $1.60 M(+529.2%) | $1.60 M(-23.7%) |
| Sep 2019 | - | $2.10 M(+0.3%) |
| Jun 2019 | - | $2.10 M(+11.0%) |
| Mar 2019 | - | $1.89 M(+640.8%) |
| Dec 2018 | $255.00 K(-38.8%) | $255.00 K(>+9900.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $307.90 K(-2.4%) |
| Mar 2018 | - | $315.60 K(-24.2%) |
| Dec 2017 | $416.50 K(+168.4%) | $416.50 K(+24.0%) |
| Sep 2017 | - | $336.00 K(-49.9%) |
| Jun 2017 | - | $671.10 K(+761.5%) |
| Mar 2017 | - | $77.90 K(-49.8%) |
| Dec 2016 | $155.20 K(-97.6%) | $155.20 K(-98.4%) |
| Sep 2016 | - | $9.93 M(+7.5%) |
| Jun 2016 | - | $9.24 M(+23.9%) |
| Mar 2016 | - | $7.46 M(+13.4%) |
| Dec 2015 | $6.58 M(+525.0%) | $6.58 M |
| Dec 2014 | $1.05 M | - |
FAQ
- What is Entero Therapeutics annual short term debt?
- What is the all time high annual short term debt for Entero Therapeutics?
- What is Entero Therapeutics annual short term debt year-on-year change?
- What is Entero Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Entero Therapeutics?
- What is Entero Therapeutics quarterly short term debt year-on-year change?
What is Entero Therapeutics annual short term debt?
The current annual short term debt of ENTO is $679.90 K
What is the all time high annual short term debt for Entero Therapeutics?
Entero Therapeutics all-time high annual short term debt is $6.58 M
What is Entero Therapeutics annual short term debt year-on-year change?
Over the past year, ENTO annual short term debt has changed by +$10.30 K (+1.54%)
What is Entero Therapeutics quarterly short term debt?
The current quarterly short term debt of ENTO is $79.50 K
What is the all time high quarterly short term debt for Entero Therapeutics?
Entero Therapeutics all-time high quarterly short term debt is $9.93 M
What is Entero Therapeutics quarterly short term debt year-on-year change?
Over the past year, ENTO quarterly short term debt has changed by -$600.40 K (-88.31%)